Literature DB >> 8227431

Use of a commercial PCR kit for detecting Chlamydia trachomatis.

I W Smith1, C L Morrison, C Patrizio, A McMillan.   

Abstract

AIMS: To evaluate a commercial polymerase chain reaction (PCR) kit for the detection of Chlamydia trachomatis.
METHODS: Two hundred and fifty seven genital specimens, which had been submitted in 2SP medium for chlamydial isolation and subsequently stored at -70 degrees C, were retrospectively examined by a commercial PCR kit which detects chlamydial plasmid DNA. Culture negative, PCR positive specimens were examined by immunofluorescence and an in-house major outer membrane protein (MOMP)-PCR.
RESULTS: All 49 specimens which were culture positive were also PCR positive. Another 14 specimens were also PCR positive. After resolution of these results by immunofluorescence and a PCR assay for MOMP the sensitivity for PCR was 98.4% and that of culture 79%. The specificities were 99.5% and 100%, respectively.
CONCLUSIONS: This kit, which is highly sensitive and specific, is straightforward to use and has a built-in safeguard against cross contamination. The role of this test in the examination of routine genital specimens from patients with uncomplicated chlamydial infection is questionable due to its expense. It may have a place in the investigation of trachoma or infertility, however, where it has been shown that DNA can be detected when culture is unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227431      PMCID: PMC501516          DOI: 10.1136/jcp.46.9.822

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

Review 1.  Laboratory techniques for the diagnosis of chlamydial infections.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  Genitourin Med       Date:  1991-06

2.  Detection of C trachomatis in urogenital specimens by polymerase chain reaction.

Authors:  H Näher; H Drzonek; J Wolf; M von Knebel Doeberitz; D Petzoldt
Journal:  Genitourin Med       Date:  1991-06

3.  Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay.

Authors:  L Bobo; B Munoz; R Viscidi; T Quinn; H Mkocha; S West
Journal:  Lancet       Date:  1991-10-05       Impact factor: 79.321

Review 4.  Detection of chlamydiae by isolation and direct examination.

Authors:  R T Evans; R M Woodland
Journal:  Br Med Bull       Date:  1983-04       Impact factor: 4.291

5.  Early detection of chlamydial inclusions combining the use of cycloheximide-treated McCoy cells and immunofluorescence staining.

Authors:  B J Thomas; R T Evans; G R Hutchinson; D Taylor-Robinson
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

6.  Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease?

Authors:  J Schachter; J Moncada; C R Dawson; J Sheppard; P Courtright; M E Said; S Zaki; S F Hafez; A Lorincz
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers.

Authors:  P Simmonds; P Balfe; J F Peutherer; C A Ludlam; J O Bishop; A J Brown
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Specific amplification of a DNA sequence common to all Chlamydia trachomatis serovars using the polymerase chain reaction.

Authors:  B Dutilh; C Bébéar; P Rodriguez; A Vekris; J Bonnet; M Garret
Journal:  Res Microbiol       Date:  1989-01       Impact factor: 3.992

9.  Chlamydia trachomatis infection of the cervix: the need for a diagnostic service.

Authors:  J M Hunter; I W Smith; J F Peutherer; A J MacAulay
Journal:  Scott Med J       Date:  1982-04       Impact factor: 0.729

10.  Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study.

Authors:  H C Claas; J H Wagenvoort; H G Niesters; T T Tio; J H Van Rijsoort-Vos; W G Quint
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  7 in total

1.  Use of a single swab in multi-microbe or flex trans transport medium for detection of Chlamydia trachomatis by Roche Amplicor PCR and culture in specimens from two different patient populations.

Authors:  C K Fong; J Falcone; M L Landry
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Differences in the sensitivity of the Amplicor Chlamydia trachomatis PCR assay.

Authors:  J M Ossewaarde; G J van Doornum; M Buimer; B Choueiri; A Stary
Journal:  Genitourin Med       Date:  1997-06

3.  Role of confirmatory PCRs in determining performance of Chlamydia Amplicor PCR with endocervical specimens from women with a low prevalence of infection.

Authors:  J B Mahony; K E Luinstra; J W Sellors; L Pickard; S Chong; D Jang; M A Chernesky
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

4.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

5.  Prevalence of Chlamydia infection among women visiting a gynaecology outpatient department: evaluation of an in-house PCR assay for detection of Chlamydia trachomatis.

Authors:  Achchhe L Patel; Divya Sachdev; Poonam Nagpal; Uma Chaudhry; Subash C Sonkar; Suman L Mendiratta; Daman Saluja
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-09-08       Impact factor: 3.944

6.  Detection of Chlamydia trachomatis in genital swabs: comparison of commercial and in house amplification methods with culture.

Authors:  R M Shattock; C Patrizio; P Simmonds; S Sutherland
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

7.  Evaluation of a commercial polymerase chain reaction assay for Chlamydia trachomatis and suggestions for improving sensitivity.

Authors:  B J Thomas; E J MacLeod; D Taylor-Robinson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.